Praxis Precision Medicines, Inc. PRAX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share?
- Praxis Precision Medicines, Inc. (PRAX) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.